secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-07-15T23:59:59+00:00
Accession:  0000950170-24-083385
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix repays $1.06M of convertible bond with shares and ADSs
----------------------------------------------------------------

- Issued 2.275M ordinary shares and 4.641M ADSs to settle $1.06M principal and interest due July 7, 2024.
- Remaining convertible bond principal reduced to $11.66M from $12.72M.
- Shares issued under Section 3(a)(9) exemption; no registration.
- 11.56M new ordinary shares to be admitted to AIM on July 17, 2024.
- Post-Admission total ordinary shares: 165,925,513; each ADS represents two ordinary shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024083385/0000950170-24-083385-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024083385/rnlx-20240715.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-083385

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer